{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:39:38Z","timestamp":1792643978739,"version":"4.5.0"},"reference-count":62,"publisher":"American Psychiatric Association Publishing","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"DOI":"10.1176\/appi.ps.20260173","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:00:13Z","timestamp":1792641613000},"source":"Crossref","is-referenced-by-count":0,"title":["Outdated Product Labeling and Implications for Contemporary Standards of Care: The Example of Clozapine"],"prefix":"10.1176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7294-4834","authenticated-orcid":false,"given":"Jonathan M.","family":"Meyer","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of California, San Diego, San Diego."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Ravin","sequence":"additional","affiliation":[{"name":"Nevada Division of Public and Behavioral Health, Las Vegas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Carruthers","sequence":"additional","affiliation":[{"name":"Bureau of Psychiatric Services, New York State Office of Mental Health, Albany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9903-8807","authenticated-orcid":false,"given":"Robert O.","family":"Cotes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Ehret","sequence":"additional","affiliation":[{"name":"University of Maryland School of Pharmacy, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Love","sequence":"additional","affiliation":[{"name":"University of Maryland School of Pharmacy, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"Information on Clozapine. Silver Spring MD US Food and Drug Administration 2025. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/information-clozapine"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25ac15898"},{"key":"e_1_3_2_4_2","unstructured":"Clozaril [package insert]. Rosemont PA HLS Therapeutics 2025. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/019758s106lbl.pdf"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.1155"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2026.112784"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1625-6388"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001987"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2026.03.012"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2025.89"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001990"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230744"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.09.019"},{"key":"e_1_3_2_14_2","first-page":"428","article-title":"The tortoise beats the hare: the case for slow clozapine titrations with serial CRP monitoring","volume":"34","author":"Cotes RO","year":"2022","unstructured":"Cotes RO, Goldsmith DR: The tortoise beats the hare: the case for slow clozapine titrations with serial CRP monitoring. Psychiatr Danub 2022; 34:428\u2013429","journal-title":"Psychiatr Danub"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13398"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-023-00412-6"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pcn5.70"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.09.029"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.09.029"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.06.003"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2024.113"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000002035"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2026.11024"},{"key":"e_1_3_2_24_2","unstructured":"VA\/DoD Clinical Practice Guideline for Management of First-Episode Psychosis and Schizophrenia. Washington DC US Department of Veterans Affairs and Department of Defense 2023. https:\/\/www.healthquality.va.gov\/HEALTHQUALITY\/guidelines\/MH\/scz\/VA-DOD-CPG-Schizophrenia-CPG_Finalv231924.pdf"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaf053"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(25)00098-7"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001843"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001924"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.70050"},{"key":"e_1_3_2_30_2","first-page":"502","article-title":"Package inserts and the standard of care","volume":"16","author":"Thornton RG","year":"2003","unstructured":"Thornton RG: Package inserts and the standard of care. Proc 2003; 16:502\u2013504","journal-title":"Proc"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/2168479018759662"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12295"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0097"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000885"},{"key":"e_1_3_2_35_2","unstructured":"Frequently Asked Questions About Labeling for Prescription Medicines for Healthcare Professionals. Silver Spring MD US Food and Drug Administration 2024. https:\/\/www.fda.gov\/drugs\/fdas-labeling-resources-human-prescription-drugs\/frequently-asked-questions-about-labeling-prescription-medicines"},{"key":"e_1_3_2_36_2","unstructured":"FDA\u2019s Labeling Resources for Human Prescription Drugs for Industry. Silver Spring MD US Food and Drug Administration 2026. https:\/\/www.fda.gov\/drugs\/laws-acts-and-rules\/fdas-labeling-resources-human-prescription-drugs"},{"key":"e_1_3_2_37_2","unstructured":"Guidance for Industry: Labeling for Human Prescription Drug and Biological Products\u2014Implementing the PLR Content and Format Requirements. Rockville MD US Food and Drug Administration Center for Biologics Evaluation and Research 2013. https:\/\/www.fda.gov\/files\/drugs\/published\/Labeling-for-Human-Prescription-Drug-and-Biological-Products---Implementing-the-PLR-Content-and-Format-Requirements.pdf"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00002-0"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12593"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.10.001"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2024.1816"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.254"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1017\/9781009225069"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/apa.16444"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000350"},{"key":"e_1_3_2_46_2","unstructured":"Lithium Carbonate Capsules [package insert]. Panelav India Alembic Pharmaceuticals 2022. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=4ca2b977-b94c-4232-9b7e-835db97c9544"},{"key":"e_1_3_2_47_2","unstructured":"Lithane (Lithium Carbonate Tablets) [package insert]. West Haven CT Miles Pharmaceuticals 2006. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=42bed965-4b8f-4471-bcc9-091f87238653"},{"key":"e_1_3_2_48_2","unstructured":"Lithium Carbonate Capsules USP [package insert]. Elmwood Park NJ Glenmark Pharmaceuticals 2025. https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=63b3790f-a9b5-47f4-bae1-ddf8b43c13c1&type=display"},{"key":"e_1_3_2_49_2","unstructured":"Digoxin Tablets USP [package insert]. East Windsor NJ Novitium Pharma 2024. https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=dba3b3f7-3ff2-4996-8653-b0e54a398bf9&type=pdf"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.70083"},{"key":"e_1_3_2_51_2","volume-title":"SK v Obstetric & Gynecologic Associates of Iowa City and Coralville, PC, 22-1317","year":"2024","unstructured":"SK v Obstetric & Gynecologic Associates of Iowa City and Coralville, PC, 22-1317 (Iowa 2024)"},{"key":"e_1_3_2_52_2","volume-title":"Mulder v Parke Davis & Company, 181 NW2d 882","year":"1970","unstructured":"Mulder v Parke Davis & Company, 181 NW2d 882 (Minn 1970)"},{"key":"e_1_3_2_53_2","volume-title":"Craft v Peebles, 78 Haw 287, 893 P2d 138","year":"1995","unstructured":"Craft v Peebles, 78 Haw 287, 893 P2d 138 (Haw 1995)"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000791"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2015.11.005"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181d070c3"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004457"},{"key":"e_1_3_2_58_2","unstructured":"Enhancing Information About Older Prescription Drugs: Can Drug Labeling Be Modernized? Washington DC Friends of Cancer Research 2017. https:\/\/friendsofcancerresearch.org\/wp-content\/uploads\/Panel-3_0.pdf"},{"key":"e_1_3_2_59_2","volume-title":"Reference Manual on Scientific Evidence","author":"Federal Judicial Center","year":"2011","unstructured":"Federal Judicial Center: Reference Manual on Scientific Evidence, 3rd ed. Washington, DC, National Academies Press, 2011","edition":"3"},{"key":"e_1_3_2_60_2","first-page":"36","article-title":"The role of practice guidelines in medical malpractice litigation","volume":"13","author":"Mackey TK","year":"2011","unstructured":"Mackey TK, Liang BA: The role of practice guidelines in medical malpractice litigation. Virtual Mentor 2011; 13:36\u201341","journal-title":"Virtual Mentor"},{"key":"e_1_3_2_61_2","volume-title":"Nishi v Hartwell, 473 P2d 116","year":"1970","unstructured":"Nishi v Hartwell, 473 P2d 116 (Haw 1970)"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000454781.67482.ad"},{"key":"e_1_3_2_63_2","unstructured":"Understanding Unapproved Use of Approved Drugs \u201cOff Label.\u201d Silver Spring MD US Food and Drug Administration 2018. https:\/\/www.fda.gov\/patients\/learn-about-expanded-access-and-other-treatment-options\/understanding-unapproved-use-approved-drugs-label"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:00:17Z","timestamp":1792641617000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.20260173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":62,"alternative-id":["10.1176\/appi.ps.20260173"],"URL":"https:\/\/doi.org\/10.1176\/appi.ps.20260173","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"article-number":"appi.ps.20260173"}}